loader

cnx:nlb

LATEST ARTICLES
psychedelics investing

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

psychedelics investing

Mydecine Innovations Group Files Application to list to the NASDAQ

psychedelics investing

Mydecine Innovations Group Included in First-Ever Psychedelics ETF

psychedelics investing

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

psychedelics investing

Mydecine Innovations Group Shares Intellectual Property Update

psychedelics investing

Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

psychedelics investing

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

psychedelics investing

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

psychedelics investing

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics

psychedelics investing

Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms

psychedelics investing

Mydecine Innovations Group to Restate Financial Statements

psychedelics investing

Mydecine Innovations Group Offers Management and Clinical Trials Update

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES